Medical Facilities Corporation
DR.TOTSXHealthcare● Active
$18.51
+$0.58(+3.23%)
Market Cap$324855109
P/E Ratio—
52W High$18.79
52W Low$13.59
Medical Facilities Corporation（DR.TO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DR.TO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.26B | $0.33B | $0.45B | $0.42B | $0.40B |
| Cost of Revenue | $0.16B | $0.11B | $0.15B | $0.14B | $0.13B |
| Gross Profit | $0.10B | $0.22B | $0.30B | $0.28B | $0.27B |
| Gross Margin %(computed) | 37.97% | 66.32% | 66.58% | 66.10% | 67.38% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.15B | $0.15B | $0.20B | $0.18B |
| Total Operating Expenses | $0.05B | $0.16B | $0.23B | $0.25B | $0.19B |
| Operating Income | $0.05B | $0.06B | $0.07B | $0.03B | $0.08B |
| Operating Margin %(computed) | 18.36% | 18.59% | 15.06% | 8.23% | 19.41% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.01B | $0.02B | $0.01B | $0.03B |
| Income Before Tax | $0.04B | $0.05B | $0.05B | $0.02B | $0.05B |
| Income Tax Expense | $0.01B | ($0.01B) | $0.01B | $0.01B | $0.00B |
| Net Income | $0.02B | $0.07B | $0.02B | ($0.00B) | $0.02B |
| Net Margin %(computed) | 8.15% | 22.17% | 4.15% | -1.04% | 3.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.09 | $1.03 | $0.73 | $0.42 | $1.50 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.06B | $0.08B | $0.07B | $0.05B | $0.10B |
| EBITDA Margin %(computed) | 22.97% | 24.91% | 16.26% | 12.05% | 25.94% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Medical Facilities Corporation
关于Medical Facilities Corporation（DR.TO）损益表
Medical Facilities Corporation（DR.TO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，DR.TO实现营收$0.26B，毛利润$0.10B（毛利率37.97%），净利润$0.02B（净利率8.15%）。
常见问题
DR.TO · 4 问Medical Facilities Corporation（DR.TO）2025财年营收为$0.26B，同比down22.0%。
DR.TO revenueDR.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08